The enhanced pre- and postnatal study for nonhuman primates: update and perspectives.

作者: Gerhard F. Weinbauer , Antje Fuchs , Michael Niehaus , Craig M. Luetjens

DOI: 10.1002/BDRC.20220

关键词:

摘要: The enhanced pre- and postnatal (ePPND) study design has been developed in response to new scientific knowledge subsequent guideline changes, that is, ICH M3(R2) S6(R1). changes were basically driven by the experiences obtained during preclinical development of biopharmaceuticals. ePPND concept typically does not apply pharmaceuticals. In essence, is a PPND which key elements an embryofetal (EFD) are being investigated newborns infants rather than fetus. current relevant nonhuman primate model cynomolgus monkey. S6(R1) reached step 4 June 2011 provides detailed recommendations on various parameters conduct study. By time this article written, it appears for monoclonal antibodies, preferred approach although also leaves options modified EFD concepts. Our data demonstrate social housing feasible developmental toxicity studies monkey model.

参考文章(28)
Kathryn L. Chapman, Nick Pullen, Laura Andrews, Ian Ragan, The future of non-human primate use in mAb development Drug Discovery Today. ,vol. 15, pp. 235- 242 ,(2010) , 10.1016/J.DRUDIS.2010.01.002
Leigh Ann Burns-Naas, Kenneth L. Hastings, Gregory S. Ladics, Susan L. Makris, George A. Parker, Michael P. Holsapple, What's so special about the developing immune system? International Journal of Toxicology. ,vol. 27, pp. 223- 254 ,(2008) , 10.1080/10915810801978110
Pauline L. Martin, Satoru Oneda, George Treacy, Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. American Journal of Reproductive Immunology. ,vol. 58, pp. 138- 149 ,(2007) , 10.1111/J.1600-0897.2007.00499.X
Eric Van Esch, J. Mark Cline, Eberhard Buse, Charles E. Wood, Eveline P. C. T. de Rijk, Gerhard F. Weinbauer, Summary Comparison of Female Reproductive System in Human and the Cynomolgus Monkey (Macaca fascicularis) Toxicologic Pathology. ,vol. 36, ,(2008) , 10.1177/0192623308327415
Kathryn Chapman, Nick Pullen, Lee Coney, Maggie Dempster, Laura Andrews, Jeffrey Bajramovic, Paul Baldrick, Lorrene Buckley, Abby Jacobs, Geoff Hale, Colin Green, Ian Ragan, Vicky Robinson, Preclinical development of monoclonal antibodies: considerations for the use of non-human primates. mAbs. ,vol. 1, pp. 505- 516 ,(2009) , 10.4161/MABS.1.5.9676
Diana J. Auyeung-Kim, Madhav N. Devalaraja, Thi-Sau Migone, Wendy Cai, Gary J. Chellman, Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reproductive Toxicology. ,vol. 28, pp. 443- 455 ,(2009) , 10.1016/J.REPROTOX.2009.07.002
A G Hendrickx, N Makori, P Peterson, Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents. Human & Experimental Toxicology. ,vol. 19, pp. 219- 225 ,(2000) , 10.1191/096032700678815756
Mari S. Golub, E. N. Sassenrath, Loring F. Chapman, Mother-Infant Interaction in Rhesus Monkeys Treated Chronically with Delta-9-Tetrahydrocannabinol. Child Development. ,vol. 52, pp. 389- 392 ,(1981) , 10.1111/J.1467-8624.1981.TB03062.X